FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768485753> ?p ?o ?g. }

• W2768485753 endingPage "107677" @default.
• W2768485753 startingPage "107666" @default.
• W2768485753 abstract "// Sho Nambara 1 , Takaaki Masuda 1 , Miki Nishio 2, 3 , Shotaro Kuramitsu 1 , Taro Tobo 4 , Yushi Ogawa 5 , Qingjiang Hu 1 , Tomohiro Iguchi 6 , Yousuke Kuroda 1 , Shuhei Ito 1 , Hidetoshi Eguchi 1 , Keishi Sugimachi 1, 6 , Hiroshi Saeki 7 , Eiji Oki 7 , Yoshihiko Maehara 7 , Akira Suzuki 2, 3 and Koshi Mimori 1 1 Department of Surgery, Kyushu University Beppu Hospital, Beppu, Oita 874-0838, Japan 2 Medical Institute of Bioregulation, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan 3 Division of Molecular and Cellular Biology, Kobe University Graduate School of Medicine, Chuo-Ku, Kobe, Hyogo 650-0017, Japan 4 Department of Pathology, Kyushu University Beppu Hospital, Beppu, Oita 874-0838, Japan 5 Digestive Disease Center, Showa University Northern Yokohama Hospital, Tsuzuki-Ku, Kanagawa 224-8503, Japan 6 Department of Gastroenterological Surgery, National Kyushu Cancer Center, Fukuoka 811-1395, Japan 7 Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan Correspondence to: Koshi Mimori, email: kmimori@beppu.kyushu-u.ac.jp Keywords: ivermectin; yes-associated protein 1 inhibitor; gastric cancer; antiproliferative effect; therapeutic target Received: May 31, 2017      Accepted: November 03, 2017      Published: November 21, 2017 ABSTRACT Yes-associated protein 1 (YAP1) acts as an oncogene through dephosphorylation and nuclear translocation, and nuclear accumulation of YAP1 is associated with poor prognosis in gastric cancer (GC). We previously identified ivermectin, an antiparasitic drug, as a YAP1 inhibitor. Here, we aimed to clarify whether ivermectin had antitumor effects on GC through inhibition of YAP1. First, we evaluated the antiproliferative effects of ivermectin on human GC cells using in vitro proliferation assays and a xenograft mouse model. YAP1-knockdown assays were performed to assess whether the sensitivity to ivermectin depended on YAP1 expression. Next, we explored the mechanism through which ivermectin regulated YAP1 expression or localization by immunoblotting and reverse transcription-quantitative polymerase chain reaction for YAP1 and the downstream gene CTGF . Finally, the clinical significance of YAP1 expression was examined using three independent GC datasets. We found that MKN1 GC cells were most sensitive to ivermectin, whereas MKN7 cells were most resistant. In MKN1 xenografts, ivermectin suppressed tumor growth, and the sensitivity of MKN1 cells to ivermectin was decreased by YAP1 knockdown. Ivermectin inhibited YAP1 nuclear expression and CTGF expression in MKN1 cells but not MKN7 cells. Moreover, ivermectin decreased YAP1 mRNA expression, thereby inhibiting nuclear accumulation of YAP1 in MKN1 cells. In survival analysis, low YAP1 mRNA expression was associated with a better prognosis in three independent GC datasets. In conclusion, we identified ivermectin as a potential antitumor agent and found a promising novel therapeutic strategy for inhibition of GC progression by blocking YAP1 expression." @default.
• W2768485753 created "2017-12-04" @default.
• W2768485753 creator A5004420462 @default.
• W2768485753 creator A5006300612 @default.
• W2768485753 creator A5013407257 @default.
• W2768485753 creator A5017398620 @default.
• W2768485753 creator A5017606167 @default.
• W2768485753 creator A5018750173 @default.
• W2768485753 creator A5020106604 @default.
• W2768485753 creator A5040954950 @default.
• W2768485753 creator A5041539430 @default.
• W2768485753 creator A5046758275 @default.
• W2768485753 creator A5057146510 @default.
• W2768485753 creator A5058931620 @default.
• W2768485753 creator A5059453591 @default.
• W2768485753 creator A5063723368 @default.
• W2768485753 creator A5067430347 @default.
• W2768485753 creator A5073472318 @default.
• W2768485753 creator A5078287634 @default.
• W2768485753 date "2017-11-21" @default.
• W2768485753 modified "2023-10-17" @default.
• W2768485753 title "Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer" @default.
• W2768485753 cites W1757407923 @default.
• W2768485753 cites W1993243592 @default.
• W2768485753 cites W2002129385 @default.
• W2768485753 cites W2016155136 @default.
• W2768485753 cites W2036586511 @default.
• W2768485753 cites W2048000549 @default.
• W2768485753 cites W2068614944 @default.
• W2768485753 cites W2082806176 @default.
• W2768485753 cites W2098318720 @default.
• W2768485753 cites W2099213341 @default.
• W2768485753 cites W2099540110 @default.
• W2768485753 cites W2105406852 @default.
• W2768485753 cites W2111509141 @default.
• W2768485753 cites W2115566490 @default.
• W2768485753 cites W2123302006 @default.
• W2768485753 cites W2134937820 @default.
• W2768485753 cites W2139160260 @default.
• W2768485753 cites W2141749176 @default.
• W2768485753 cites W2159310898 @default.
• W2768485753 cites W2167978765 @default.
• W2768485753 cites W2225462341 @default.
• W2768485753 cites W2279541196 @default.
• W2768485753 cites W2310968520 @default.
• W2768485753 cites W2313387517 @default.
• W2768485753 cites W2322763157 @default.
• W2768485753 cites W2327362588 @default.
• W2768485753 cites W2470094136 @default.
• W2768485753 cites W2550941463 @default.
• W2768485753 cites W4251925149 @default.
• W2768485753 doi "https://doi.org/10.18632/oncotarget.22587" @default.
• W2768485753 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5746098" @default.
• W2768485753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29296196" @default.
• W2768485753 hasPublicationYear "2017" @default.
• W2768485753 type Work @default.
• W2768485753 sameAs 2768485753 @default.
• W2768485753 citedByCount "31" @default.
• W2768485753 countsByYear W27684857532018 @default.
• W2768485753 countsByYear W27684857532019 @default.
• W2768485753 countsByYear W27684857532020 @default.
• W2768485753 countsByYear W27684857532021 @default.
• W2768485753 countsByYear W27684857532022 @default.
• W2768485753 countsByYear W27684857532023 @default.
• W2768485753 crossrefType "journal-article" @default.
• W2768485753 hasAuthorship W2768485753A5004420462 @default.
• W2768485753 hasAuthorship W2768485753A5006300612 @default.
• W2768485753 hasAuthorship W2768485753A5013407257 @default.
• W2768485753 hasAuthorship W2768485753A5017398620 @default.
• W2768485753 hasAuthorship W2768485753A5017606167 @default.
• W2768485753 hasAuthorship W2768485753A5018750173 @default.
• W2768485753 hasAuthorship W2768485753A5020106604 @default.
• W2768485753 hasAuthorship W2768485753A5040954950 @default.
• W2768485753 hasAuthorship W2768485753A5041539430 @default.
• W2768485753 hasAuthorship W2768485753A5046758275 @default.
• W2768485753 hasAuthorship W2768485753A5057146510 @default.
• W2768485753 hasAuthorship W2768485753A5058931620 @default.
• W2768485753 hasAuthorship W2768485753A5059453591 @default.
• W2768485753 hasAuthorship W2768485753A5063723368 @default.
• W2768485753 hasAuthorship W2768485753A5067430347 @default.
• W2768485753 hasAuthorship W2768485753A5073472318 @default.
• W2768485753 hasAuthorship W2768485753A5078287634 @default.
• W2768485753 hasBestOaLocation W27684857531 @default.
• W2768485753 hasConcept C121608353 @default.
• W2768485753 hasConcept C126322002 @default.
• W2768485753 hasConcept C142724271 @default.
• W2768485753 hasConcept C2777499811 @default.
• W2768485753 hasConcept C2781018059 @default.
• W2768485753 hasConcept C2781421772 @default.
• W2768485753 hasConcept C29537977 @default.
• W2768485753 hasConcept C42972112 @default.
• W2768485753 hasConcept C71924100 @default.
• W2768485753 hasConceptScore W2768485753C121608353 @default.
• W2768485753 hasConceptScore W2768485753C126322002 @default.
• W2768485753 hasConceptScore W2768485753C142724271 @default.
• W2768485753 hasConceptScore W2768485753C2777499811 @default.
• W2768485753 hasConceptScore W2768485753C2781018059 @default.
• W2768485753 hasConceptScore W2768485753C2781421772 @default.

• next